Anti-Human CD138 Monoclonal Antibody, Azide Free Clone B-A38

Product Code: 854.070.000

Supplier: Diaclone

Code	Size	Price

854.070.000

200ug/200ul

£320.00

Quantity:

Prices exclude any Taxes / VAT

Overview

Host Type: Mouse

Antibody Isotype: IgG1

Antibody Clonality: Monoclonal

Antibody Clone: B-A38

Regulatory Status: RUO

Target Species: Human

Applications:

Storage:

Store at +2-8°C for 12 months. For longer storage, freeze aliquots

Antigen:

CD138 / Syndecan-1

Antigen Synonyms:

Syndecan-1

Conjugate:

Azide free

Format:

Phosphate-buffered saline. Sterile-filtered through 0.22 µm. Carrier and preservative free

Hybridoma:

Myeloma X63/AG.8653 x Balb/c spleen cells

Immunisation:

U266 cell line

Reactivity:

Human

Research Area:

Cell Adhesion,CD Markers

Specificity:

Recognises Syndecan-1, the heparan sulfate proteoglycan, a 65-70 kDa protein

Gheorghe, K. R. et al., PLoS One,2011; 6(1): e16378. Prostaglandin E2 synthesizing enzymes in rheumatoid arthritis B cells and the effects of B cell depleting therapy on enzyme expression. https://www.ncbi.nlm.nih.gov/pubmed/21298002
Kliment, C. R. et al., J. Biol. Chem.,2009; 284(6): 3537-3545.. Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis.. https://www.ncbi.nlm.nih.gov/pubmed/19073610
Proust, A. et al., Am J Pathol.,2011; 179(4): 1630-7. p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression.. https://www.ncbi.nlm.nih.gov/pubmed/21871426
Revu, S. et al., Arthritis Res Ther.,2013;15(6): R205. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.. https://www.ncbi.nlm.nih.gov/pubmed/24295447
Withers, D. et al., Blood,2007;109(11)4856-64. T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. https://www.ncbi.nlm.nih.gov/pubmed/17299094
Yang, Y. et al., Blood,2007;110(6):2041-8. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. https://www.ncbi.nlm.nih.gov/pubmed/17536013